Recent advances and current issues in single-cell sequencing of tumors

Cancer Lett. 2015 Aug 28;365(1):1-10. doi: 10.1016/j.canlet.2015.04.022. Epub 2015 May 21.

Abstract

Intratumoral heterogeneity is a recently recognized but important feature of cancer that underlies the various biocharacteristics of cancer tissues. The advent of next-generation sequencing technologies has facilitated large scale capture of genomic data, while the recent development of single-cell sequencing has allowed for more in-depth studies into the complex molecular mechanisms of intratumoral heterogeneity. In this review, the recent advances and current challenges in single-cell sequencing methodologies are discussed, highlighting the potential power of these data to provide insights into oncological processes, from tumorigenesis through progression to metastasis and therapy resistance.

Keywords: Intratumoral heterogeneity; Sequencing analysis; Single-cell sequencing; Tumor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / genetics*
  • Biomarkers, Tumor / metabolism
  • Cell Separation
  • Drug Resistance, Neoplasm / genetics
  • Genetic Predisposition to Disease
  • High-Throughput Nucleotide Sequencing / methods*
  • Humans
  • Molecular Targeted Therapy
  • Neoplasms / drug therapy
  • Neoplasms / genetics*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Phenotype
  • Precision Medicine
  • Predictive Value of Tests
  • Sequence Analysis, DNA / methods*
  • Single-Cell Analysis / methods*
  • Transcriptome

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor